IMC
IMMURON FPO [IMC]
Healthcare · ASX Small Cap
$0.0280 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +13First seen: 2026-02-25
Score Breakdown
Technical35
Catalyst51
Sentiment50
Fundamental64
Momentum40
Risk Gate38
Active Signals
Bullish Signals
- RSI approaching oversold
- Sustained volume spike (2.6x median) on DOWN trend
- Strong cash runway (9 quarters)
- Low P/S ratio (1.2x)
- Near 52-week low (1% of range)
- Micro-cap ($5-20M) - high risk
- Altman Z-Score in grey zone (2.24)
- Low-priced stock risk ($0.028)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. 2017-10-30)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-62%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-49%)
Recent Catalysts
NONE Change in substantial holding
NONE Strategic Update and HY26 Results
NONE Appendix 4D and Half Year Report
Recent ASX Announcements
| 2026-02-26 | Change in substantial holding |
| 2026-02-25 | Strategic Update and HY26 Results PRICE SENSITIVE |
| 2026-02-25 | Appendix 4D and Half Year Report PRICE SENSITIVE |
| 2026-02-17 | Immuron receives R&D Tax Incentive |
| 2026-02-12 | Results of Meeting |
Key Metrics
$9.1M
Market Cap
245K
Avg Volume
2.6x
Vol Ratio
$0.03 — $0.10
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-39.7%
ROE
-62.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 84% |
| L | Leader vs Laggard | laggard | RS: -12 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #17 of 119 · Sector avg: 51
View all Healthcare signals →